Jiawang Zhu

Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of <i>N</i>-Aryl Cinnamides

Elizabeth M. Doherty, Christopher Fotsch, Yunxin Bo et al. · Journal of Medicinal Chemistry · 2004 · 102 citations · Full text

Transient Receptor Potential, Molecular Pain, Pharmacotherapy +16

Novel Vanilloid Receptor-1 Antagonists:  2. Structure−Activity Relationships of 4-Oxopyrimidines Leading to the Selection of a Clinical Candidate

Elizabeth M. Doherty, Christopher Fotsch, Anthony W. Bannon et al. · Journal of Medicinal Chemistry · 2007 · 98 citations · Full text

Silylcarbocyclizations of 1,6-Diynes

Iwao Ojima, Jiawang Zhu, Ephraim S. Vidal et al. · Journal of the American Chemical Society · 1998 · 74 citations

Engineering, Heterocyclic, Sicab Processes +7

Novel Vanilloid Receptor-1 Antagonists:  1. Conformationally Restricted Analogues of<i>trans</i>-Cinnamides

Mark H. Norman, Jiawang Zhu, Christopher Fotsch et al. · Journal of Medicinal Chemistry · 2007 · 42 citations · Full text

Pain Medicine, Transient Receptor Potential, Molecular Pain +17

New and Efficient Catalytic Route to Bicyclo[3.3.0]octa-1,5-dien-3-ones

Iwao Ojima, Dora Fracchiolla Kass, Jiawang Zhu · Organometallics · 1996 · 30 citations

Engineering, Heterocyclic, 4,4-Disubstituted 1,6-Heptadiynes +10